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Purpose:  Rigorous  comprehensive  evaluations  of primary  healthcare  (PHC)  quality  improve-
ment (QI)  initiatives  are  lacking.  This  article  describes  the  evaluation  of the  Quality
Improvement  and  Innovation  Partnership  Learning  Collaborative  (QIIP-LC),  an  Ontario-
wide PHC  QI program  targeting  type  2  diabetes  management,  colorectal  cancer  (CRC)
screening,  access  to  care,  and  team  functioning.
Methods:  This  article  highlights  the primary  outcome  results  of  an external  retrospective,
multi-measure,  mixed-method  evaluation  of the  QIIP-LC,  including:  (1)  matched-controluality improvement
pre-post  chart  audit  of  diabetes  management  (A1c/foot  exams)  and  rate  of CRC  screening;nterdisciplinary teams
iabetes
olorectal cancer screening
dvanced access
valuation
(2)  post-only  advanced  access  survey  (third-next  available  appointment);  and  (3)  post-only
semi-structured  interviews  (team  functioning).
Results:  Chart  audit  data  was  collected  from  34  consenting  physicians  per  group  (of  which
88%  provided  access  data).  Between-group  differences  were  not  statistically  signiﬁcant
(A1c  [p =  0.10];  foot  exams  [p = 0.45];  CRC  screening  [p  = 0.77];  advanced  access  [p =  0.22]).
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Qualitative  interview  (n  =  42)  themes  highlighted  the success  of  the program  in helping
build  interdisciplinary  team  functioning  and capacity.
Conclusion:  The  rigorous  design  and  methodology  of  the QIIP-LC  evaluation  utilizing  a  con-
trol group  is  one  of the  most  signiﬁcant  efforts  thus  far to  demonstrate  the  impact  of  a  QI
program  in  PHC,  with  improvements  over  time  in  both  QIIP and  control  groups  offering  a
likely  explanation  for the  lack  of  statistically  signiﬁcant  primary  outcomes.  Team  function-
ing was  a key  success,  with  team-based  chronic  care  highlighted  as  pivotal  for improved
health  outcomes.  Policy  makers  should  strive  to endorse  QI  programs  with  proven  success
through  rigorous  evaluation  to ensure  evidence-based  healthcare  policy  and  funding.
rs.  Publ
Y-NC-N©  2014  The  Autho
the  CC  B
1. Introduction
Primary healthcare is the foundation of any high-
performing healthcare delivery system [1,2]. When orga-
nized and utilized to be effective and efﬁcient, better
healthcare can be achieved at lower costs, with successful
early detection of disease, secondary prevention of illness,
and improved health and well-being of individuals with
chronic disease [2]. This can all be done within an envi-
ronment that is familiar, comfortable, and accessible for
patients [2]. Large-scale reforms targeting the Ontario pri-
mary healthcare system have been implemented over the
past decade striving for this ideal, with a transition from
a reactive model of acute, episodic care, to a proactive
patient-centred system focused on health promotion, dis-
ease prevention, and chronic disease management [1,3–5].
One such reform introduced Family Health Teams (FHTs)
in 2005 in Ontario, Canada, primary health care organi-
zations characterized by: (1) group practice and practice
networks; (2) patient enrolment and rostering; (3) changes
to PHC governance and accountability; (4) funding and
compensation; (5) creation of multidisciplinary care teams
including family physicians, nurse practitioners/registered
nurses, and other health care professionals (for exam-
ple, social workers and dieticians); (6) internet technology
infrastructure; and (7) education/training with a focus
on quality improvement [3,6–8]. Similar to the team-
based organization of Community Health Centres (CHCs),
these transformations presented signiﬁcant challenges to
those delivering care, including the need to develop new
care processes, make meaningful use of new technol-
ogy, and adapt team-based approaches for chronic disease
prevention and management [9–12]. To support primary
healthcare organizations in Ontario with these challenges,
the Quality Improvement and Innovation Partnership
(QIIP), now amalgamated with Health Quality Ontario
(HQO), was established as a provincial organization by the
Ministry of Health and Long-Term Care (MOHLTC) in 2008.
1.1. Quality Improvement and Innovation Partnership
Between 2008 and 2010, the QIIP launched three waves
of a quality improvement (QI) learning collaborative (LC)
program based on the Institute for Healthcare Improve-
ment Breakthrough Series (IHI-BTS) adult-learning model
[13] and the Model for Improvement strategy of using
small tests of change to determine impact prior to largerished  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under
D  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
scale implementation [14]. Incorporating the concepts of
the Chronic Disease Prevention and Management Frame-
work [15], the purpose of this program was  to educate,
train, and enable primary healthcare teams to improve
chronic disease management and outcomes of the popula-
tion they serve by providing effective, efﬁcient, accessible,
comprehensive, and patient-centred, team-based health-
care. The LCs were designed to target the challenges of
developing and adopting a chronic disease management
approach by providing participants opportunities to learn
to work together as a PHC team, and better utilize allied
healthcare provider skills to improve care and adherence
to clinical practice guidelines. Program activities focused
on assisting interdisciplinary teams within FHTs and CHCs
to: (1) improve type 2 diabetes (T2DM) management;
(2) increase colorectal cancer (CRC) screening; (3) opti-
mize patient access to primary healthcare (“advanced
access”); and (4) improve team functioning. These four
topic areas served as proxies for the ability of FHTs and
CHCs to improve care in three domains: (1) chronic dis-
ease management; (2) disease prevention; and (3) ofﬁce
access and efﬁciency. Each wave of the QIIP-LC program
consisted of three learning sessions, two action peri-
ods between the learning sessions, and one summative
congress at the end. The learning sessions introduced
Plan-Do-Study-Act (PDSA) methodology [16] and Ontario’s
CDPM framework [15]. A description of the program is
provided in Table 1, with a detailed program logic model
pending publication. Participation in the QIIP-LC program
was  voluntary and open to primary healthcare organiza-
tions across Ontario.
1.2. Evaluation of quality improvement initiatives
QI initiatives have the potential to improve chronic
disease management, health promotion and disease pre-
vention; however there have been few evaluations to
support their signiﬁcant ﬁnancial and programmatic
investment. More rigorous and comprehensive evaluations
are needed to examine the effects of these programs on
health outcomes and sustainability [17–23]. Thus, a rigor-
ous and comprehensive external evaluation was designed
to examine the impact of the QIIP-LC program on T2DM
management, CRC screening, advanced access, and team
functioning. Building from lessons learned from the recent
evaluation of the Partnerships for Health program (PFH),
a similar QI initiative in primary healthcare in Ontario,
Canada [24], this evaluation incorporated a control group
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Table  1
QIIP learning collaborative program characteristics.
Length of the program The program was  delivered over three waves of learning col|laboratives from 2008 to 2010. The
length of each wave of learning collaborative from pre-work to Congress ranged from 15.5 to 17
months
Pre-work Teams were required to (a) form a working group within their organizations who would
participate in program activities that was  representative of all key clinical (family physicians,
allied healthcare professionals) and administrative roles, (b) deﬁne the patient population, (c)
familiarizing themselves with the Collaborative Charter, measurements, and monthly reporting
scheme, (d) develop a team statement and a story board, and (e) participate in two conference
calls to learn about methodology
Learning sessions/Congress Learning Session 1 (two days): Education about Chronic Disease Prevention and Management
(CDPM) Framework, Model for Improvement and PDSA cycles, access and ofﬁce efﬁciency,
delivery system design, patient education for self-management, measures for improvement,
electronic medical record (EMR) information management, diabetes care and management, CRS,
process mapping, community resources and partnership, decision support, and team
leadership.Learning Session 2 (two days): Content related to ofﬁce practice redesign, process
mapping, use of EMR, care process design, speciﬁc ofﬁce process changes to better manage
diabetes and to improve colorectal cancer screening, work as an interdisciplinary team, and
community partnership.Learning Session 3 (two days): Re-cap of material, education on spread
of  lessons learned and improvement to other colleagues, education on sustainability of QI, factors
that  impact QI, and creative thinking and innovation.Congress (half day): Showcased teams’
achievements and lessons learned; attended by organization leaders (FHT, CHC, professional
leaders, primary healthcare decision makers) as strategy to spread and sustain improvements;
guest speakers and panel discussions.
Action periods (between learning
sessions/congress)
Implement QI activities in the practice; identify areas for improvement; implement PDSA cycles;
collect data from EMR; report on monthly measures
Practice coaches/facilitators Monitored teams’ performance and provide assistance to ensure the teams were able to adhere to
the program activities; on-site visits; attended team meetings; review monthly report
Teleconferences Teams provided and discussed information presented at learning sessions, lessons learned and
experiences.
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. Methods
Investigators external to the program implementation
eam conducted a rigorous mixed-method, multi-measure
valuation of the QIIP-LC program on T2DM management,
RC screening, advanced access to care, and team func-
ioning. The evaluation included: (1) development of a
ogic model and assessment oriented process evaluation
f the program; (2) a cluster, matched-control, pre-post
hart audit on the management of T2DM and rate of CRC
creening; (3) a controlled post-only survey of practices
articipating in the chart audit on advanced access to
ealthcare; (4) semi-structured, post-only, in-depth tele-
hone interviews; (5) post-only web-based participant
urvey; and (6) health administrative data analysis with
he Institute for Clinical Evaluative Sciences (ICES).
This paper presents the results of the chart audit,
dvanced access survey, and interviews related to the
mpact of the QIIP-LC program on the primary outcomes:
2DM management (glycated haemoglobin [A1c] and foot
xams), CRC screening, advanced access, and team func-
ioning.Evaluation of the QIIP-LC program was approved by the
esearch Ethics Board at The University of Western Ontario
nd Queens University. A waiver of patient consent for the
hart audit was granted under the Ontario Personal Healthion with project implementation team and other participating teams
load monthly reporting measures
Information Protection Act (PHIPA) from the Ethics Review
Boards.
2.1. Participants
2.1.1. Quantitative – chart audit and advanced access
survey
Primary healthcare (PHC) teams (family physicians,
allied care providers, and administrative staff) from FHTs
and CHCs across Ontario were randomly selected from a
sampling framework based on the proportion of teams by:
(1) model of care (FHT/academic FHT/CHC); (2) practice
setting (rural/urban); (3) wave of LC; and (4) geographical
region (Local Health Integration Networks were grouped
into regions). Teams were considered eligible for the
evaluation if they joined the QIIP-LC program and did not
formally withdraw. One PHC QIIP-LC physician per team
was randomly recruited for the chart audit and survey.
Matched controls were non-participating physicians iden-
tiﬁed based on the sampling framework of their matched
QIIP-LC physician. To maximize the effectiveness of the
control group, and minimize the risk of contamination,
potential control physicians were identiﬁed using a prag-
matic priority approach. Control physicians practicing
in FHTs were, ideally, recruited within the same FHT
organization as QIIP-LC teams (but not located at the same
practice site), and ranked according to distance from their
matched QIIP physician. Control physicians practicing in
CHCs were recruited from separate CHC organizations
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Table 2
Quantitative primary outcome measures and patient chart eligibility criteria.
Program focus Primary outcome measure(s) Patient chart eligibility criteria Timeline of data collection
Type 2 diabetes mellitus
(T2DM) management
• The proportion of patients with
an annual foot exam (process
measure)
• A1c value of patients above study
target A1c (≥7.3%) at baseline
(clinical outcome measure)
• Rostered to the physician at least
one year prior to the program
• Did not leave the practice or
deceased
• At least 18 years of age
• Diagnosed with type 2 diabetes
• Diagnosed at least one year prior
to the program
• Retrospectively from 12
months prior to each
physician’s start date in the
QIIP-LC program to 12 months
following the end of the
program
Colorectal cancer (CRC)
screening
• Proportion of eligible patients
screened for CRC (deﬁned as
referral/requisition of FOBT,
sigmoidoscopy, or colonoscopy)
• Rostered to the physician at least
one year prior to the program
• Did not leave the practice or
deceased
• Between the age of 50 and 75
• No colonoscopy in the past ﬁve
years
• No prior history of colon cancer
• Retrospectively from 24
months prior to each
physician’s start date in the
program to 24 months after
their start date
•  Two independent samples of
patients were randomly
selected for each 24-month
period
s • Advanced access • The number of regular clinic day
until the third-next available
appointment.
(CHCs typically operate at one practice site). Physicians
were eligible if they had been in practice at least one
year prior to the commencement of the QIIP-LC with a
minimum of 20 patients with T2DM in their practice.
2.1.2. Qualitative semi-structured interview
PHC team participants were selected using a two-
step sampling process. First, 10 teams were purposefully
selected from a sampling framework similar to the chart
audit to ensure representation by model of care, practice
setting and geographical region. Second, a purposeful and
iterative sampling strategy was used to select participants
reﬂecting maximum variation in clinical and adminis-
trative roles and to ensure that both the physician and
executive leads from each of the teams were included. Four
senior program administrators from the QIIP-LC imple-
mentation team and seven QI coaches were also selected
as key informants.
2.2. Measures and data collection
2.2.1. Quantitative – chart audit and advanced access
survey
Primary outcome measures were identiﬁed for each
area of focus of the LCs (see Table 2). For diabetes care
the proportion of documented foot exams was selected as
the best process measure as prior research had demon-
strated this had the greatest opportunity for improvement,
while a reduction in A1c value for patients above tar-
get A1c values (A1c ≥ 7.3% at baseline) was selected as a
measurable clinical outcome. The A1c study target was
deﬁned as 7.3% rather than the Canadian Diabetes Asso-
ciation Clinical Practice Guideline of 7% [25] to identify
patients in whom glycemic treatment intensiﬁcation was
more likely. For colorectal cancer screening the pro-
portion of patients who received guideline concordant
screening (referral/requisition of FOBT, sigmoidoscopy, or
colonoscopy) was the primary outcome. For advancedNot applicable
access, the primary outcome was time (days) to third next
available appointment.
Chart audit: Consenting physicians generated a list of
patients with T2DM (ICD-9, 250 billing code) and a second
list of patients, aged 50–75, for CRC screening based on year
of birth and pre-deﬁned evaluation dates. Trained auditors
randomly selected patients from each list and screened for
eligibility criteria until sample size requirements were met.
Patient chart eligibility and timeframe of data collection
are described in Table 2. Data collection timeframes were
based on dates of participation in QIIP-LC program and, for
control physicians, were based on the participation dates
of their matched physician participant.
Advanced access survey: The advanced access survey
was  developed by the external evaluation team based on a
review of literature. The survey was  administered to those
practices participating in the chart audit component of the
evaluation to determine the impact of the QIIP-LC program
on access to healthcare, and included assessment of the
number of days to the third-next available appointment
as well as questions on past and current models of access
at the practice level (traditional, open access, advanced
access). The survey included instructions for measuring
the number of days until the third-next-available appoint-
ment, and a table to complete with the dates for the ﬁrst,
second, and third-next-available appointment (including
date and time of measurement). To reduce the effect of sea-
sonal changes on appointment variability, the surveys were
sent once all physicians were recruited for the chart audit.
2.2.2. Qualitative semi-structured interview
To obtain the views of participants, the QIIP imple-
mentation team, and QICs, individual telephone interviews
(45–90 min) were conducted by a trained facilitator 12
months after the program ended. Semi-structured inter-
view guides were developed in alignment with the QIIP-LC
program activities to explore the experiences, perspectives
and impact of the QIIP-LC program on the management of
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2DM, CRC screening, and advanced access, as well as the
evelopment of team functioning. Interview guides further
dentiﬁed major facilitators and barriers that participants
aced, overall perceptions of the QIIP-LC, and recorded par-
icipants’ levels of satisfaction with the QIIP-LC program.
nterviews was audiotaped and transcribed verbatim, with
ach transcript proof-read by the interviewer to ensure
ccuracy.
.3. Sample size
.3.1. Chart audit and advanced access survey
Sample size calculations were conducted adjusting for
lustering and loss to follow-up for the three quantitative
rimary outcomes (T2DM management [A1c/foot exams],
RC screening and advanced access). The magnitude of
hange from baseline used in power calculations to demon-
trate a clinically signiﬁcant improvement included: A1c
0.50%); foot exam and CRC screening (20%); and advanced
ccess (four days to third next-available appointment).
aking into account the sample size requirements for each
utcome, the ﬁnal number of physicians required per group
as 33.
.3.2. Qualitative Semi-structured Interview
Saturation of themes was ensured by having 10 PHC
eams (each with a minimum of two and a maximum of
our team members) that reﬂected maximum variation
y model of care, practice setting, geographic region, and
linical/administrative roles. Additionally, senior program
dministrators from the QIIP-LC implementation team, and
uality improvement coaches (QICs) who had worked with
he selected teams during the QIIP-LC were recruited and
nterviewed.
.4. Analysis
.4.1. Quantitative – chart audit and advanced access
urvey
Chart Audit: Analyses were performed on all outcomes
sing SAS 9.2 (©SAS Institute Inc.). The generalized lin-
ar model (Proc Genmod) was used to compare change
n outcome measures from baseline between the QIIP-LC
hysician (hereafter reported as QIIP group) and control
roup. Analyses accounted for clustering within the physi-
ian’s practice and controlled for baseline measures.
Advanced access survey: A Mann–Whitney test was per-
ormed to compare the number of days until the third-next
vailable appointment of the QIIP and control practices.
.4.2. Qualitative semi-structured interview
Each transcript was coded in parallel by two research
taff using NVivo9 software. Data analysis was conducted
sing an iterative and interpretive approach. In the ﬁrst
hase of the analysis each transcript was independently
eviewed and coded by the researchers to determine the
ey concepts emerging from the data. The researchers then
et  to examine their independent coding, culminating in
 consensus that informed the development of the coding
emplate. The second iteration of the analysis involved gen-
ration of summaries for each of the main themes with 119 (2015) 405–416 409
exemplar quotes illustrating the themes. The strategy of
immersion and crystallization further assisted in synthe-
sizing the data to provide a comprehensive overview of
the key themes [26–28]. Saturation was reached after 31
participant interviews.
3. Results
3.1. Quantitative primary outcome results
Fig. 1 displays the physician recruitment, consent,
and the number of patient charts audited. A total of 34
physicians per group consented/completed the chart audit
component. Physician and patient demographics were sim-
ilar (Table 3). For the advanced access survey, 88% of
physicians provided outcome data.
Primary outcome result between QIIP and control
groups are summarized in Table 4. Participation in the QIIP-
LC did not have a signiﬁcant effect on T2DM management
(A1c, p = 0.10; foot exams, p = 0.45), rate of CRC screening
(p = 0.77), or advanced access to healthcare (p = 0.22) when
compared to the control group; however both groups
showed a trend towards improvements over time. Mean
A1c for patients above study target (A1c ≥ 7.3%) was  sig-
niﬁcantly lower in the QIIP group during the program
(p = 0.01); however these improvements were not sus-
tained 12 months following program completion.
3.2. Qualitative ﬁndings
A total of 31 primary healthcare participants, four
QIIP senior program administrators, and seven quality
improvement coaches consented to participate in the inter-
views. In this section of the paper, qualitative themes
are presented to align with the four goals of the QIIP-LC
program: (1) improve T2DM management; (2) increase
CRC screening; (3) optimize patient access to primary
healthcare (“advanced access”); and (4) improve team
functioning.
3.2.1. T2DM management
Overall, QIIP-LC participants perceived that they
strengthened their diabetes monitoring and made efforts
to improve diabetes process (foot exams), and outcome
(A1c) measures to follow clinical practice guidelines more
closely.
I certainly would say that we have seen an improvement
in the A1c levels and that’s myself learning more about
diabetes and diabetes management, being more com-
fortable with initiating newer medications and insulin.
So the A1c levels have improved and I think lipid results
have improved as well. (PHC Team)
Teams developed various strategies to systematically
follow-up and track patients by developing diabetes
registries, ﬂow sheets and reminder systems in EMRs, fos-
tering a sense of improved care by ensuring appropriate
and timely follow-up: “For diabetes, if you didn’t come, before
no one knew and no one cared. Now if you don’t show up,
you are invited back”. (PHC Team). “[Patient care] certainly
has improved by making sure that people are being screened
410 S.B. Harris et al. / Health Policy 119 (2015) 405–416
onsent,Fig. 1. Physician recruitment, c
appropriately, having regular A1cs, lipids, foot care, eye exams.
I think that’s probably the most signiﬁcant change”. (PHC
Team)
Similarly, diabetes education was perceived to be
enhanced.
“If you have diabetes, we are checking your A1c, we  are
referring you to a dietitian. We’re running groups and
classes. We  encourage patients to attend these things.
So I think at the end there’s much better patient care”.
(PHC Team)
Table 3
Baseline demographic characteristics of physicians and patients.
QIIP 
Physician demographics
Physicians, N 34 
Females, % (n) 41.2 (14) 
Mean  years in practice (SD)a 23.1 (10.51) 
Rural,  % (n) 52.9% (18) 
Patient demographics (foot exam)
Patient, N 406 
Females, % (n) 46.6 (189) 
Mean  age, year (SD) 62.3 (11.43) 
Mean  duration of T2DM, year (SD) 6.2 (6.32) N = 31
Patient demographics (A1cc)
Patient, N 153 
Females, % (n) 45.8 (70) 
Mean  age, year (SD) 54.7 (11.92) 
Mean  duration of T2DM, year (SD)b 6.9 (5.89) N = 11
Patient demographics (CRC screening)
Patients, N (baseline/post) 814 (407/407) 
Females, % (n) 53.6 (436)a
Mean  age, year (SD) 59.5 (6.64) 
a Two  patients with missing data.
b No signiﬁcant difference between groups (p = 0.16).
c Patients above study target A1c ≥ 7.3%. and number of patient charts.
However, some participants had not observed any
change in clinical outcomes for diabetes. “The clinical out-
comes don’t really reﬂect any signiﬁcant change”. (PHC Team)
This was consistent with the QIIP senior program adminis-
trators, who observed inconsistent improvement in clinical
outcomes across practices that participated in the QIIP-
LC. “The improvements that we saw in reported data were
inconsistent across practices. Some made huge gains and
they made them quickly, others made smaller gains, and
some didn’t make any improvements in the measured out-
Control
34
44.1 (15)
21.2 (9.07)
52.9% (18)
403
50.9 (205)
62.9 (12.28)
6 6.0 (5.61) N = 324
157
49.0 (77)
50.4 (12.77)
9 8.4 (6.82) N = 120
801 (399/402)
52.7 (422)
59.9 (6.89)
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Table  4
Comparison of quantitative primary outcomes for QIIP and control.
T2DM management Baseline During P-value between
group (baseline to
duringc)
Post P-value between group
(baseline to postc)
Mean A1c % value (SD)a QIIP 8.5 (1.25) 8.1 (1.32) 0.01 8.2 (1.62) 0.10
Control 8.5 (1.22) 8.4 (1.51) 8.4 (1.58)
Foot  exam, % (n) QIIP 28.6 (116) 49.3 (200) 0.20 48.5 (197) 0.15
Control 24.8 (100) 35.0 (141) 38.0 (153)
CRC screening QIIP Control P-value Between group
(baseline to follow-upc)
Baseline Follow-up Baseline Follow-up
Screened for CRCb, % (n) 57.7 (235) 66.1 (269) 51.1 (204) 61.7 (248) 0.77
Access QIIP Control P-value between groups
Mean number of days until third-next
available appointment (SD)
5.3 (10.5) 6.6 (8.8) 0.221
Range  0–55 0–41
a Patients above study target (A1c ≥ 7.3%).
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c T2DM management: baseline = 12 months prior to the learning colla
aseline = 24 months prior to the learning collaborative; follow-up = 24 m
omes”. (QIIP-LC senior program administrator) One major
hallenge observed by QIIP-LC senior program administra-
ors was the variability in the EMR  systems limiting data
xtraction.
The number one barrier from my  perspective was  the
EMR’s. . . we lost probably the ﬁrst three or four months
just in the standardization of input data and the chal-
lenge of getting data back out of the system. It wasn’t
such a big issue with access and efﬁciency because we
didn’t need the EMR  for that, but for diabetes and CRC
screening, extracting clinical information was  painful.
(PHC Team)
.2.2. CRC screening
Many of the participants from the primary healthcare
eams reported that their CRC screening rates improved
fter their participation in the QIIP-LC due to a redesign of
are processes. Teams developed various schemes to iden-
ify eligible patients for CRC screening, educated patients
bout the importance of cancer prevention, and followed
p the FOBT kits that were sent out.
We’ve gone after patients. Before if you didn’t show
up, you didn’t get offered screening. That was problem
number one. Now if people are outside the range that
they’re supposed to be in, they will get called, inviting
them to come in and have a conversation about colo-
rectal screening, which of course creates more patient
demand. (PHC Team)
Furthermore, with increased awareness of CRC preven-
ion among the providers and improved tracking systems,
hey were able to identify at-risk patients based on retur-
ing test results and refer patients in a timely fashion for
 colonoscopy or to specialists for further treatment. “We
ad an increase in FOBT results back, which means that we
lso had an increase in screening, and we worked on a pro-
ess for ensuring that the referral was done within a two week
eriod.” (PHC Team); post = 12 months post learning collaborative end date; CRC screening:
llowing the start of the learning collaborative.
PHC team participation in the PDSA cycles promoted by
the QIIP-LC were credited with some of the improvements
experienced by the PHC teams.
Originally there were the low 50s or high 60s percent-
ages of his [physician lead] patients who needed to be
screened, were being screened by the end of the pro-
gram. It was after doing several PDSAs and so forth [that
we got], up into the high 90s. (PHC Team)
Some teams encountered challenges when implemen-
ting CRC screening in their practices. One challenge was
patient engagement in returning the FOBT kits. “We  put in
more protocols that would help remind patients. but you can
lead a horse to water, you can’t make him drink.” (PHC Team)
Another challenge was have a systematic way  of document-
ing in the clinic EMR. “CRC screening for us was fairly straight
forward. It was being well managed, [we] just didn’t have a
good documentation trail electronically.” (PHC Team)
Some teams found it challenging to focus QI on more
than one area with the time constraints of a busy clinic.
“To be honest, there wasn’t a lot of work done around CRC
screening for us. We  chose to work mostly with diabetes
and access and efﬁciency.” (PHC Team)
3.2.3. Advanced access
The QIIP-LC senior program administrators observed an
improvement in access to care for those teams that were
successful at implementing the advanced access model.
For the practices that were successful in implementing
advanced access, the beneﬁts to patients have got to be
major. I’ve run into friends and acquaintances whose
docs have moved to advanced access and they’re just
stunned when they phone and they’re asked when they
would like to come in, as opposed to ‘what do you want
to come in for?’ (QIIP-LC senior program administrator)
However, the PHC team participants reported various
levels of improvement in access to care. Some participants
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stated that they were able to implement a full advanced
access model in their practice.
Because we are the only family physicians ofﬁce in the
whole town, each of our doctors were at least two  to
three weeks before their appointment, some of them
six to eight weeks before you could get an appointment.
Going to advanced access took that literally down to
zero. So for our patients it was a radical change. And
our patients love it. (PHC Team)
Most PHC team participants perceived that the
improvement in access was a result of modifying the
advanced access model to meet the needs of their practices.
“It’s been a non-stop three years of changing how we sched-
ule clients. Are we as effective as we need to be? I don’t think
so. I would say we’ve gone to what’s more modiﬁed advanced
access.” (PHC Team)
Advanced access and staff changes were reported as
challenges for rural FHTs who often work part-time across
different settings. “I’m only in the ofﬁce with this patient pop-
ulation one or two days a week. . . I felt overwhelmed with
same or next day access because I can’t do that for my  [clinic]
patient population with the practice set up this way.” (PHC
Team) As well, the teams encountered patients who  did not
“buy in” to the idea of the advanced access model.
Teams expressed varied opinions on the preferences of
patients to changes in advanced access. Some participants
perceived advanced access and efﬁciency as beneﬁcial to
patients: “They get in quicker, they get the answers to their
questions.”(PHC Team) “Deﬁnitely they love the increased
access. They love being able to see multiple providers. . .”
(PHC Team).  Alternatively, other participants perceived
their patients’ preference remaining with their traditional
means of receiving care. “Some patients have been with their
doctors for many years and had satisfaction with this kind of
continuity of care. They were not interested in a shortened
cycle if it meant seeing a resident.” (PHC Team)
3.2.4. Team functioning
A central theme that emerged in the analysis was team
readiness for change, a key ingredient to the working as
a team and successful participation in the QIIP-LC. ‘Readi-
ness’ was characterized by: previous experience with QI
and data management; adopting a team-approach with
attention to team functioning and communication strate-
gies; reﬂective practice; openness to external advice and
support; openness to sharing lessons learned, including
both positive and negative data; comfort with trial and
error; and having an understanding of the difference
between accountability and QI. Successful teams needed
to demonstrate a willingness and commitment to the
process.
Teams that had already gotten over the kind of initial
organizational hurdles of establishing their team and
doing what they had to do to recruit their personnel, and
at least had started to work on building a team climate
within the organization [had better success with the
program]. Others just had so much other work on their
plate that it just wasn’t feasible. . . There were still FHTs
at the end who were still struggling, just around staff 119 (2015) 405–416
recruitment, team functioning and getting parameters
sorted out. (QIIP-LC senior program administrator)
By requiring a composition of interdisciplinary profes-
sional roles in each team, the QIIP-LC program provided
participants with the opportunity to learn from each other
and improve the delivery of primary care in an inter-
disciplinary team fashion. “Learning about other people’s
viewpoints which aren’t necessarily your viewpoint was good
for colleagues.” (PHC Team) As a consequence, they gained
an increased understanding of other’s roles and scope of
practice. “It really helped see everybody’s role.” (PHC Team)
“We’ve learned how to communicate with each other, and
generally through process mapping, what other individuals
do and what other individuals need to do their job prop-
erly.” (PHC Team) Furthermore, there was  more perceived
trust and respect among team members, and less profes-
sional silos. “Because of the increased collaboration among
the different people on the team, it has empowered our front
staff and our nursing staff to feel more comfortable coming
to us directly with patient concerns.” (PHC Team) “We  actu-
ally developed as a collaborative team, where before we’d
been working much more as separated silos, doing our own
thing.” (PHC Team) They experienced how a team approach
enhanced the delivery of care.
We  developed a team approach to diabetes care . . . The
goals that the patient sets are stated with the diabetes
educator and then the family doctor reinforces what the
goals are for the next visits. (PHC Team)
Teams also reported improved team dynamics by shar-
ing a team vision and common goals. Teamwork was
recognized as an integral success factor in improving care
for patients.
It was  good to be exposed to this kind of bigger pic-
ture thinking. It was the networking, the ability to get
together with others who are passionate about improv-
ing health care and excited to work as a team towards
making situations better for our patients. (PHC Team)
Lastly, teams reported that care to patients was
improved because of improved team functioning in
practice. “Patients get much better care. They have a team
effort looking after them instead of an individual.”
So ultimately if you have a team that’s functioning well,
and doing better assessments, you have better patient
outcomes. Sometimes that’s better patient care, [even if
it is not] better patient outcomes, [because] its tough to
measure particularly by numerical numbers and speciﬁc
guidelines. But there is overall improvement in health
care based on the improvement of the team. I think the
two  are absolutely linked. (PHC Team)
4. Discussion
The QIIP-LC program did not demonstrate statisti-
cally signiﬁcant between-group differences in the primary
outcome measures (T2DM management: A1c [p = 0.10];
foot exams [p = 0.45]; rate of CRC screening [p = 0.77]; or
advanced access to healthcare [p = 0.22]). Improvements
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ver time for physicians in both QIIP and control groups
ikely explains the lack of statistically signiﬁcant primary
utcomes to support the QIIP-LC program; however other
haracteristics of the program or evaluation design may
ave contributed to these results and will be described in
etail below. These qualitative ﬁndings resonate with the
uantitative results and reﬂect triangulation of the multi-
le datasets in this mixed-method evaluation.
The QIIP-LC program was successful in helping
uild interdisciplinary team functioning and capacity
hrough improved team interactions and collaborations,
n increased understanding of each other’s roles, and
ncreased information and resource sharing. Interview
ndings illuminate the more nuanced and implicit ele-
ents of perceived team formation and interaction.
eadiness was a key ingredient to successful participa-
ion in the QIIP-LC, a consistent theme in the literature
ital for the success of a program [29–31]. Understand-
ng each other’s role emerged as an important component
f team building, [29] and participants described experi-
ncing more trust and respect among team members and
ewer professional silos within their teams. Participants
lso described how a team approach enhanced the deliv-
ry of care – they were able to provide better care for
heir T2DM patients, work together to implement a process
here more patients were screened for CRC, and demon-
trated more coordinated administrative and clinical staff
fforts focused on working together for more timely patient
are.
.1. Explanation of study ﬁndings
Although the QIIP-LC chart audit and interview ﬁndings
emonstrated a trend towards improved delivery of care
or patients with diabetes, and efforts to improve T2DM
anagement and CRC screening (proxy for chronic disease
anagement and disease prevention), these improve-
ents did not translate into statistically signiﬁcant
ifferences between the QIIP and control groups. These
esults are consistent with previously published literature
or T2DM management looking at annual foot exams and
ean A1c [32], and rates of CRC screening [33]. Similarly,
xamination of advanced access scheduling and themes
merging from participant interviews indicated concerted
ction to improve access to healthcare, with no statisti-
ally signiﬁcant differences in wait times for appointments
etween groups. Interview ﬁndings highlighted many chal-
enges and barriers faced by teams in their attempt to
mplement an advanced access model, including factors
utside of a physician’s control (for example, patient’s
esistance to change), and again, these ﬁndings were con-
istent with the advanced access literature [34].
As noted above, other characteristics of the QIIP-LC pro-
ram or evaluation may  have contributed to the primary
utcome results. QIIP-LC participants were encouraged to
pread lessons learned to colleagues, which may  have led
o some degree of contamination and improvements noted
n the control group. For example, while both the mean
nd median number of days to the third-next-available
ppointment was lower for the QIIP group, the magni-
ude of the difference was  below the level required (three 119 (2015) 405–416 413
days or more) for the size of this study and not statistically
signiﬁcant. This could be an indication that changes initi-
ated by QIIP-LC participants were integrated into the whole
practice organization and thus, control practices within
the same FHT may  have adopted the new model. Future
research could consider interviewing the control group to
elucidate the impact of the program and spread of lessons
learned between groups.
Qualitative themes highlight some of the underlying
challenges physicians and teams faced during the QIIP-LC
program that may  have impacted the primary outcome
results, including limited resources to extract data from
electronic medical records to allow teams to measure indi-
cators of quality of care (and thus put the teams ‘behind’
schedule in the LC), the challenge of focusing on more than
one QI area at a time in a busy clinic setting, and factors
outside of a physician’s control, like patient follow-through
and resistance to change. Additionally, the duration of
the program and/or evaluation was perhaps insufﬁcient to
affect or detect differences in outcomes. The newly formed
interdisciplinary teams were only beginning to learn to
work as a team [35] and varied in their degree of readiness
to change practice. Chin et al. [36] reported that it can take
as many as four years after participating in a QI program
before A1c values are decreased signiﬁcantly. Alterna-
tively, the QIIP-LC program may  have been strengthened by
assisting teams with skills to sustain lessons learned. Sta-
tistically signiﬁcant improvement in foot exams and A1c
were noted during the program between QIIP and control
groups; however, these improvements were not sustained
upon program completion.
4.2. Contribution to existing literature
The majority of published QI evaluation studies have
relied on self-reported measures and made minimal use
of control groups [17–19,24]. Difﬁculties in evaluating
complex interventions in health research have been well
documented [37], and this evaluation used an innovative,
controlled, retrospective, multi-measure, mixed-method
design to cultivate and enhance the ﬁeld of QI evalua-
tion literature with a robust research design offering a
breadth of detail about the impact of a QI collaborative in
primary healthcare [18,37]. The purpose of an evaluation
is to determine whether results are, in fact, a result of
the intervention, and use of this rigorous quantitative
methodology with stratiﬁed random selection of partici-
pants, strengthened by a control group, provides a clearer
understanding of the impact of the QIIP-LC on program
participants. Use of a control group in the QIIP-LC eval-
uation demonstrates the rigour that should be expected
in the future when evaluating QI initiatives. The QIIP-LC
program evaluation was further strengthened by a mixed-
method research design, allowing triangulation of the
qualitative and quantitative ﬁndings, and offered insight
into some of the underlying factors that may  explain the
results presented here-in. The retrospective nature of
the evaluation offered protection against detection bias,
with the primary outcome measures unknown to the
participants during the QIIP-LC program. The qualitative
interviews were representative of the participating teams,
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with maximum variation in clinical and administrative
roles within the team, illuminating the more nuanced and
implicit elements of the QIIP-LC program.
Second, organizations involved in the design and imple-
mentation of QI programs must take other local, regional or
provincial primary healthcare programs or initiatives into
consideration to optimize the impact of the QI program.
While the QIIP-LC program was underway, the MOHLTC ran
parallel programming and incentives to family physicians
across Ontario for diabetes management, CRC screening,
and advanced access to comply with best practices. These
programs may  have contributed to the improvements seen
in both QIIP and control groups, and may  explain the lack
of statistically signiﬁcant primary outcomes to support the
QIIP-LC program [38–42]. Furthermore, many FHTs and
CHCs were in the process of implementing a mandated EMR
which may  have contributed to improvements seen in both
groups [43–45]. QI programs must be judiciously designed
to improve care above and beyond related initiatives in the
environment to ensure added value, particularly given the
ﬁnancial and resource intensive nature of QI LCs. As is evi-
dent in this research and existing literature, QI LCs have
the potential to improve primary healthcare and team-
based care, and this research highlights the importance of
prioritizing evaluation of these initiatives to inform future
program planning, evaluation and health policy.
Third, to be able to evaluate the success of these
programs, the implementation team must consider evalua-
tion prior to program implementation. Program evaluation
should become a central tenet of QI initiatives, with small
scale pilot studies evaluated prior to wide-spread pro-
grammatic roll-out [2,3,13]. This will ensure resources are
tailored to ensure maximum impact. The QIIP-LC program
may  have been limited in its effectiveness by targeting too
many areas for improvement, thus overwhelming partic-
ipants and reducing the effect of the intervention, or the
program content may  not have sufﬁciently addressed bar-
riers to QI and with sufﬁcient intensity to overcome clinical
inertia [46]. These kinds of issues regarding implementa-
tion strategies of programs need to be effectively addressed
by management teams at the beginning of any initiative if
the programs are to yield detectable differences in evalu-
ation outcomes. Long-term research on the sustainability
of QI LCs and additional research on a program’s effective-
ness are needed to inform QI planning, implementation,
and evaluation.
4.3. Evaluation limitations
The QIIP-LC program evaluation was conducted in a
real-world setting, and therefore had a number of limi-
tations with participation bias on multiple levels. Clinical
teams who volunteered to participate in the program may
have been more agreeable to changing their practice, and
this bias may  have been further heightened by the need
to have informed consent to participate in the evaluation.
Similarly, control physicians may  have had a particular
interest in the evaluation outcomes, suggesting that these
physicians may  have had a vested interest in improv-
ing their practice. The design of the evaluation may  have
also presented a number of limitations. The retrospective 119 (2015) 405–416
nature of the evaluation limited the design to matched con-
trols and a one time cross-sectional mean for advanced
access. A change in advanced access over time would have
been a better measure, and future research should con-
sider using a prospective, pre-post approach. Furthermore,
the decision to recruit control physicians from the same
FHT as QIIP-LC physicians to ensure matching by model of
care and resources may  have contributed to a degree of
contamination. Lastly, physicians or team members in the
control group were not interviewed to explore their level
of exposure to the QIIP-LC or determine if they were partic-
ipating in other interventions. Determining an appropriate
control group is often difﬁcult in an environment where
other factors or changes may  be taking place [47,48]; how-
ever future research could look at expanding the qualitative
component to the control group to offer insight into poten-
tial contamination and seek to mitigate these concerns.
4.4. Recommendations for future QI programs and
evaluation in primary healthcare
To be able to effectively evaluate the success of QI
programs, comprehensive program evaluation should be
conducted concurrently with program implementation,
with spread to other practices limited until after the evalua-
tion is complete, or controlled for in the evaluation design
(for example, qualitative interviews of both intervention
and control groups) to elucidate the impact of the program.
This will ensure a program or strategy is evaluated and
thus evidence-based and positioned to inform policy mak-
ers and practitioners. Furthermore, a cost-effectiveness
analysis should be included in all future evaluations to
support the signiﬁcant ﬁnancial investment of QI pro-
grams like QIIP, and to guide health policy and planning.
Lastly, education programs where primary healthcare clini-
cians and administrators learn together, and work together,
should be supported, with a particular emphasis on pre-
participation work to ensure team members have an
adequate understanding of workload and programmatic
requirements prior to program involvement. By partici-
pating together, team functioning is enhanced and as is
evident through this evaluation, a key success of QI ini-
tiatives like QIIP. Recent literature supports the potential
of interprofessional, team-based care, and it would be pru-
dent for health policy and funding to continue to endorse
QI programs in PHC designed to enhance collaborative and
interprofessional team-based care for patients with chronic
conditions [49–52].
5. Conclusion
Improvements over time for physicians in both QIIP and
control groups likely explains the lack of statistically sig-
niﬁcant primary outcomes to support the QIIP-LC program.
Other characteristics of the QIIP-LC program or evaluation
design may  have contributed to these results, including the
intensity of the program, selection of controls, contamina-
tion between QIIP and control groups, or other concomitant
reasons. The qualitative ﬁndings resonate with the
improvements noted in the QIIP group’s quantitative
results and reﬂect triangulation of the multiple datasets in
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his mixed-method evaluation. The QIIP-LC program was
uccessful in helping build interdisciplinary team function-
ng and capacity through improved team interactions and
ollaborations, an increased understanding of each other’s
oles, and increased information and resource sharing.
QI-LCs like QIIP are designed to target the challenges
f developing a chronic disease management strategy
y providing participants the opportunity to learn to
ork together as a team and optimize allied healthcare
rovider skills to improve care and adherence to guide-
ines for patients. Improved prevention, management of
hronic diseases, access to healthcare and efﬁcient ofﬁce
ractice design may  signiﬁcantly reduce the strain on
ntario’s healthcare system, and continued emphasis must
e placed on the evaluation of these initiatives in primary
ealthcare to inform decision makers with evidence-based
nformation to guide healthcare policy, planning, and
unding.
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